Ultrasensitive dual-quenching electrochemiluminescence immunosensor for prostate specific antigen detection based on...

Early monitoring of prostate-specific antigen (PSA) is crucial in diagnosis and proactive treatment of prostate disease. Herein, a dual-quenching ternary ECL immunosensor was designed for PSA detection based on graphitic carbon nitride quantum dots (g-CNQDs, as an emitter), potassium persulfate (K₂S₂O₈, as a coreactant), and silver nanoparticles doped multilayer Ti₃C₂ MXene hybrids (Ag@TCM, as a coreaction accelerator). First, Ag@TCM was immobilized on the surface of a glassy carbon electrode, then g-CNQDs was further adsorbed on Ag@TCM to acquire a higher initial ECL signal at a potential window from - 1.3 to 0.0 V (vs. Ag/AgCl). Ag@TCM not only acted as the coreaction accelerator, but also as a matrix to load enormous g-CNQDs and prostate-specific capture antibody via Ag-N bond. Meanwhile, prostate-specific detection antibody was marked by gold nanoparticles modified manganese dioxide as a dual-quenching probe (Ab2- Au@MnO₂). When Ab2-Au@MnO₂ was introduced into the ternary ECL system via sandwiched immuno-reaction, the high-sensitive detection of PSA was achieved by the dual-quenching effect, caused by the resonant energy transfer from g-CNQDs (energy donor) to Au@MnO₂ (energy acceptor). As a result, this ECL immunosensor showed a good dynamic concentration range from 10 fg·mL^-1 to 100 ng·mL^-1 with a detection limit of 6.9 fg·mL^-1 for PSA detection. The dual-quenching ECL strategy presented high stability and good specificity to open up a new pathway for ultrasensitive immunoassay.